DCF — MEDSTAR FRANKLIN SQUARE MEDICAL CTR
Enterprise Value: $-526.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-526.4M
Enterprise Value
$-174.1M
PV of Cash Flows
$-352.3M
PV of Terminal Value
$-567.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $553.7M | $-28.7M | -5.0% | $-52.1M | $-47.4M |
| Year 2 | $570.3M | $-23.8M | -4.0% | $-48.0M | $-39.6M |
| Year 3 | $587.5M | $-18.7M | -3.0% | $-43.5M | $-32.7M |
| Year 4 | $605.1M | $-16.2M | -3.0% | $-41.8M | $-28.6M |
| Year 5 | $623.2M | $-15.1M | -2.0% | $-41.5M | $-25.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-526.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$537.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05678720388178038
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5